Figure 3.

Time course change of the frequency of the primary adverse events during thalidomide monotherapy. Somnolence, fever, and neutropenia emerged in the first 2 weeks, and their frequency declined over time. In contrast, the frequency of peripheral neuropathy, constipation, and dry mouth increased gradually with increasing duration of treatment,
peripheral neuropathy;
dry mouth;
constipation;
somnolence;
fever;
neutropenia.